A common liver disease affecting nearly 30% of adults worldwide may be far more complicated than scientists previously ...
BioSpectrum India on MSN
Fatty liver disease management: antifibrotic treatment, disease staging and transplant eligibility
Fatty liver disease is common, but it needs timely attention when inflammation and scarring begin. Non-Alcoholic ...
A six-month course of an experimental hepatitis B virus (HBV) drug, given alongside standard antiviral therapy, has achieved a functional cure in about 20 per cent of participants across two efficacy ...
A new Houston Methodist Research Institute study finds that older adults with metabolic dysfunction-associated steatotic liver disease (MASLD) who received GLP-1-based treatment experienced ...
Scientists have discovered that a potential new drug can reverse severe fatty liver disease in animal models by restoring gut ...
A new update from the American Gastroenterological Association (AGA) urges stronger prevention efforts and better early-detection tools for hepatocellular carcinoma (HCC), the leading cause of ...
SYDNEY--Australia's CSL said on Monday it has entered into an exclusive agreement with Alentis Therapeutics to jointly develop and promote a rare kidney and liver disease treatment.
NORTH CHICAGO, Ill., Nov. 13, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced new data for its pan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results